Goc A, Niedzwiecki A, Rath M
Dr Rath Research Institute BV, Santa Clara, CA, USA.
J Appl Microbiol. 2017 Sep;123(3):637-650. doi: 10.1111/jam.13523. Epub 2017 Aug 1.
Borrelia sp., a causative pathogenic factor of Lyme disease (LD), has become a major public health threat. Current treatments based on antibiotics often lead to relapse after their withdrawal. Naturally derived substances that could work synergistically to display higher efficacy compared with the individual components may serve as a resource for the development of novel approaches to combat both active and latent forms of Borrelia sp.
Using checkerboard assay, we investigated the anti-borreliae reciprocal cooperation of phytochemicals and micronutrients against two species of Borrelia selected as prevalent causes of LD in the United States and Europe. We tested 28 combinations of phytochemicals such as polyphenols (baicalein, luteolin, rosmarinic acids), fatty acids (monolaurin, cis-2-decenoic acid) and micronutrients (ascorbic acid, cholecalciferol and iodine). The results showed that the combinations of baicalein with luteolin as well as monolaurin with cis-2-decenoic acid expressed synergistic anti-spirochetal effects. Moreover, baicalein and luteolin, when combined with rosmarinic acid or iodine, produced additive bacteriostatic and bactericidal effects against typical corkscrew motile spirochaetes and persistent knob/round-shaped forms, respectively. An additive anti-biofilm effect was noticed between baicalein with luteolin and monolaurin with cis-2-decenoic acid. Finally, application of the combination of baicalein with luteolin increased cytoplasmic permeability of Borrelia sp. but did not cause DNA damage.
These results show that a specific combination of flavones might play a supporting role in combating Borrelia sp. through either synergistic or additive anti-borreliae effects.
Presented here in vitro results might help advancing our knowledge and improving the approach to target Borrelia sp.
莱姆病(LD)的致病病原体伯氏疏螺旋体已成为主要的公共卫生威胁。目前基于抗生素的治疗在停药后常导致复发。与单一成分相比,能协同发挥作用以显示更高疗效的天然衍生物质,可能成为开发对抗伯氏疏螺旋体活跃和潜伏形式新方法的资源。
我们采用棋盘法,研究了植物化学物质和微量营养素对两种在美国和欧洲作为LD常见病因的伯氏疏螺旋体的抗螺旋体协同作用。我们测试了28种植物化学物质组合,如多酚类(黄芩素、木犀草素、迷迭香酸)、脂肪酸(月桂酸单甘油酯、顺式-2-癸烯酸)和微量营养素(抗坏血酸、胆钙化醇和碘)。结果表明,黄芩素与木犀草素以及月桂酸单甘油酯与顺式-2-癸烯酸的组合表现出协同抗螺旋体作用。此外,黄芩素和木犀草素与迷迭香酸或碘组合时,分别对典型的螺旋状运动螺旋体和持续性瘤状/圆形形态产生相加的抑菌和杀菌作用。黄芩素与木犀草素以及月桂酸单甘油酯与顺式-2-癸烯酸之间存在相加的抗生物膜作用。最后,黄芩素与木犀草素组合的应用增加了伯氏疏螺旋体的细胞质通透性,但未导致DNA损伤。
这些结果表明,黄酮类化合物的特定组合可能通过协同或相加的抗伯氏疏螺旋体作用,在对抗伯氏疏螺旋体中发挥辅助作用。
此处展示的体外研究结果可能有助于增进我们的认识,并改进针对伯氏疏螺旋体的方法。